|Source||Humanized (from mouse)|
|(what is this?)|
Cantuzumab ravtansine (huC242-SPDB-DM4) is an antibody-drug conjugate designed for the treatment of cancers. The humanized monoclonal antibody cantuzumab (huC242) is linked to a cytotoxic agent, ravtansine (DM4). It uses a more hindered disulphide linkage than Cantuzumab mertansine.
- World Health Organization (2011). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 105" (PDF). WHO Drug Information. 25 (2).
- Antibody-Drug Conjugates and Immunotoxins: From Pre-Clinical Development to ...
|This monoclonal antibody-related article is a stub. You can help Wikipedia by expanding it.|